STOCK TITAN

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Pfizer announces a public webcast featuring discussions with Andrew Baum, Chief Strategy and Innovation Officer, and Dave Denton, Chief Financial Officer, at the Jefferies London Healthcare Conference on November 20, 2024, at 9:00 a.m. GMT. The webcast will be accessible through www.pfizer.com/investors, with registration details available immediately. A transcript and replay will be provided within 24 hours and remain accessible for 90 days.

Pfizer annuncia una webcast pubblica in cui discuteranno Andrew Baum, Chief Strategy and Innovation Officer, e Dave Denton, Chief Financial Officer, durante il Jefferies London Healthcare Conference il 20 novembre 2024, alle 9:00 GMT. La webcast sarà accessibile tramite www.pfizer.com/investors, con i dettagli per la registrazione disponibili immediatamente. Sarà fornita una trascrizione e una registrazione entro 24 ore e sarà accessibile per 90 giorni.

Pfizer anuncia una transmisión web pública que contará con la participación de Andrew Baum, Chief Strategy and Innovation Officer, y Dave Denton, Chief Financial Officer, en la Conferencia de Salud de Jefferies Londres el 20 de noviembre de 2024, a las 9:00 a.m. GMT. La transmisión estará disponible a través de www.pfizer.com/investors, con detalles de registro disponibles de inmediato. Se proporcionará una transcripción y repetición dentro de las 24 horas y permanecerá accesible durante 90 días.

화이자Andrew Baum (Chief Strategy and Innovation Officer)와 Dave Denton (Chief Financial Officer)와 함께 제프리 런던 헬스케어 컨퍼런스에서 2024년 11월 20일 오전 9시(그리니치 표준시)부터 진행되는 공개 웹캐스트를 발표합니다. 웹캐스트는 www.pfizer.com/investors를 통해 접근 가능하며, 등록 세부정보는 즉시 제공됩니다. 전사본 및 재생은 24시간 이내에 제공되며, 90일간 접근할 수 있습니다.

Pfizer annonce un webinaire public avec Andrew Baum, Directeur de la Stratégie et de l'Innovation, et Dave Denton, Directeur Financier, lors de la Conférence de Santé Jefferies à Londres le 20 novembre 2024 à 9h00 GMT. Le webinaire sera accessible via www.pfizer.com/investors, avec les détails d'inscription disponibles immédiatement. Une transcription et un enregistrement seront fournis dans les 24 heures et resteront accessibles pendant 90 jours.

Pfizer kündigt ein öffentliches Webcast an, in dem Andrew Baum, Chief Strategy and Innovation Officer, und Dave Denton, Chief Financial Officer, am Jefferies London Healthcare Conference am 20. November 2024 um 9:00 Uhr GMT diskutieren werden. Das Webcast wird über www.pfizer.com/investors zugänglich sein, wobei die Registrierungsdetails sofort verfügbar sind. Ein Protokoll und eine Aufzeichnung werden innerhalb von 24 Stunden bereitgestellt und bleiben für 90 Tage zugänglich.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Andrew Baum, Chief Strategy and Innovation Officer, Executive Vice President, and Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 9:00 a.m. GMT.

To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; our anticipated operating and financial performance, including financial guidance and projections; reorganizations, business plans, strategy and prospects; strategic reviews; capital allocation objectives; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Finance

Media Contact:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226

Investor Contact:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

When is Pfizer (PFE) presenting at the Jefferies London Healthcare Conference 2024?

Pfizer is presenting at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 9:00 a.m. GMT.

How can I watch Pfizer's (PFE) presentation at the 2024 Jefferies Healthcare Conference?

You can watch the presentation by visiting www.pfizer.com/investors, where registration details and access information are available.

How long will Pfizer's (PFE) 2024 Jefferies Conference webcast be available for replay?

The webcast replay and transcript will be available on www.pfizer.com/investors within 24 hours after the live discussion and will remain accessible for at least 90 days.

Which Pfizer (PFE) executives are speaking at the 2024 Jefferies London Healthcare Conference?

Andrew Baum, Chief Strategy and Innovation Officer, and Dave Denton, Chief Financial Officer, will be speaking at the conference.

Pfizer Inc.

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Stock Data

148.16B
5.66B
0.05%
67.8%
1.09%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW YORK